U.S. Tech Hardware Stock News

NasdaqGS:FSUN
NasdaqGS:FSUNBanks

Is FirstSun Capital Bancorp (FSUN) Price Attractive After Recent Sector Reassessment?

Wondering whether FirstSun Capital Bancorp at around US$36.06 is giving you good value right now? This breakdown will help you judge the price with a clear set of valuation tools. The stock has returned 1.5% over the last 7 days, while the 30 day return is a 1.1% decline and the year to date move sits at a 4.6% decline, with a 4.5% decline over the past year and a 28.8% gain over 3 years. Recent coverage has focused on the bank's position within the wider US banking sector and how regional...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Commvault And NetApp Alliance Puts Closed Loop Recovery In Focus

Commvault Systems and NetApp have entered a new alliance to deliver integrated data protection and cyber resilience solutions for enterprises. The partnership combines Commvault's threat detection and recovery tools with NetApp's AI driven data platform to support secure, automated recovery. The joint offering introduces a closed loop recovery architecture aimed at addressing ransomware risk and growing AI focused data workloads. Commvault Systems (NasdaqGS:CVLT) is partnering with NetApp...
NYSE:FICO
NYSE:FICOSoftware

Assessing Fair Isaac (FICO) Valuation After A Sharp Multi Month Share Price Pullback

Fair Isaac (FICO) has attracted fresh attention after a sharp pullback, with the stock down about 28% over the past month and roughly 43% over the past 3 months. See our latest analysis for Fair Isaac. The recent 28% 1 month share price return and 38.5% year to date share price decline sit alongside a 44.9% 1 year total shareholder return drop but a 3 year total shareholder return above 40%, suggesting momentum has faded after a strong multi year run. If this pullback has you reassessing your...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Director’s Share Purchase Signals Renewed Insider Confidence In Gibraltar Industries

Director James S. Metcalf recently made a significant open market share purchase in Gibraltar Industries. This is his first open market buy since November 2024 and meaningfully increases his direct holdings. The transaction comes after a year of share price underperformance for NasdaqGS:ROCK. Gibraltar Industries, traded as NasdaqGS:ROCK, is drawing fresh attention after Director James S. Metcalf increased his direct ownership through a sizeable open market purchase. The move comes at a...
NYSE:ASGN
NYSE:ASGNIT

Is ASGN (ASGN) Now Offering Value After A 40% One Year Share Price Fall

If you are wondering whether ASGN at a last close of US$37.56 is starting to look interesting on price alone, the valuation story behind that headline number is where things get more revealing. Over the past week the stock returned 4.1%, but that sits against a 12.4% decline over 30 days, a 19.5% decline year to date, and a 40.4% decline over 1 year that may have changed how investors view both risk and reward. Those returns sit within a longer slide, with 3 year and 5 year returns of 54.6%...
NYSE:ASH
NYSE:ASHChemicals

Is It Time To Reassess Ashland (ASH) After The Recent Share Price Pullback?

If you are asking whether Ashland shares offer fair value at around US$53.18, it helps to first line up the recent share price moves with what the fundamentals might justify. The stock has recently shown a sharp mix of returns, with a 9.0% gain over the last 7 days sitting alongside a 14.7% decline over 30 days, an 11.1% decline year to date, and a 7.1% decline over 1 year, as well as weaker 3 and 5 year returns of 44.6% and 35.4% declines respectively. These moves have brought Ashland back...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Should Trinity Capital’s New JV and Dividend Moves Reshape Income Expectations for TRIN Investors?

In March 2026, Trinity Capital Inc. declared monthly regular dividends of US$0.17 per share for April, May, and June 2026, and also committed US$50,000,000 in growth capital to Sage Health, while forming a new joint venture with Capital Southwest Corporation to invest in first-out senior secured debt. Together, the healthcare financing commitment, the equal US$50,000,000 joint venture with Capital Southwest, and the continued monthly dividends highlight Trinity Capital’s focus on income...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Does Rocket Lab (RKLB) Securing ESA Launches Quietly Reframe Its Government Backlog Narrative?

Rocket Lab Corporation recently completed its first dedicated launch for the European Space Agency, carrying the Celeste navigation demonstration satellites to low Earth orbit on its Electron rocket from New Zealand. This mission adds ESA to Rocket Lab’s roster of national space program customers, reinforcing its role as a commercial launch provider for government navigation and technology demonstration projects. We’ll now examine how securing ESA as a launch customer could influence Rocket...
NYSE:HG
NYSE:HGInsurance

Is It Time To Reassess Hamilton Insurance Group (HG) After Its 43% One Year Surge?

If you are wondering whether Hamilton Insurance Group's current share price still offers value after a strong run, the recent numbers give you plenty to think about. The stock closed at US$28.61, with a 0.2% move over the last 7 days, a 9.4% decline over 30 days, a 4.9% gain year to date, and a 43.5% return over the last year. These mixed short term moves against a strong 1 year return have put the focus squarely on what investors are now willing to pay for Hamilton Insurance Group and why...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

The Bull Case For Ionis Pharmaceuticals (IONS) Could Change Following FDA Priority Review For Zilganersen

Ionis Pharmaceuticals recently announced that the FDA has accepted for Priority Review its New Drug Application for zilganersen, an investigational RNA-targeted therapy for the rare and often fatal neurological disorder Alexander disease, based on a pivotal study showing clinically meaningful stabilization in gait speed and supportive safety data. This milestone underscores Ionis’s ability to advance antisense oligonucleotide medicines into late-stage regulatory review for ultra-rare...
NYSE:RRC
NYSE:RRCOil and Gas

A Look At Range Resources (RRC) Valuation After Recent Share Price Momentum

What Recent Performance Says About Range Resources Range Resources (RRC) has drawn fresh attention after a strong recent run, with the stock showing positive moves over the past week, month and past 3 months that stand out against its longer term record. See our latest analysis for Range Resources. The recent 1-day share price return of 1.75% and 30-day share price return of 15.43% sit alongside a 1-year total shareholder return of 22.76% and 5-year total shareholder return of about 3.5x...
NYSE:CFR
NYSE:CFRBanks

A Look At Cullen/Frost Bankers (CFR) Valuation As Growth Slows And Tangible Book Outlook Weakens

Recent commentary on Cullen/Frost Bankers (CFR) has focused on its slowing revenue growth compared with the five-year trend, projected declines in tangible book value, and softer capital generation, all contributing to a more cautious profitability outlook. See our latest analysis for Cullen/Frost Bankers. The recent concerns around slower revenue growth and a softer outlook on tangible book value sit against a mixed price picture. Cullen/Frost Bankers is trading at US$133.70 after a 3.8% 90...
NYSE:OGE
NYSE:OGEElectric Utilities

Assessing OGE Energy (OGE) Valuation As Mixed Returns And DCF Signals Draw Attention

Why OGE Energy (OGE) is on investors’ radar today Recent trading in OGE Energy (OGE) has brought the stock back into focus, with short term returns mixed across the past week and month while longer periods show different patterns for shareholders. See our latest analysis for OGE Energy. At a share price of US$47.54, OGE Energy has recently seen a mix of short term moves and stronger medium term momentum, with a 90 day share price return of 10.82% alongside a 1 year total shareholder return of...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Microchip SiP Launch Highlights Auto Growth Potential Despite Weak Share Momentum

Microchip Technology (NasdaqGS:MCHP) introduced its new automotive grade SAM9X75D5M System in Package hybrid MCU, targeting next generation automotive and industrial designs. The device combines processor and DDR memory in a single package to support embedded displays, connectivity and real time operating systems as well as Linux based systems. The launch is aimed at applications such as digital cockpits, EV charging systems and smart instrument clusters, where display performance and supply...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Assessing Sallie Mae’s Valuation After A Strong Earnings Beat And 16.4% Revenue Growth

Why SLM’s latest quarter is drawing fresh attention SLM (SLM) has come back into focus after reporting revenue growth of 16.4% year on year and topping analyst EPS and revenue estimates, a combination that often prompts investors to reassess the stock. See our latest analysis for SLM. The strong quarter has come against a mixed share price backdrop, with a recent 8.64% 1 month share price return offset by a 25.72% year to date share price decline and a 28.18% 1 year total shareholder return...
NasdaqGM:ATAI
NasdaqGM:ATAIPharmaceuticals

Is It Time To Reassess AtaiBeckley (ATAI) After Its Recent Share Price Slide?

If you are wondering whether AtaiBeckley's recent share price really reflects its underlying worth, you are not alone. The stock last closed at US$3.35, with returns of a 4.0% decline over 7 days, 7.7% decline over 30 days, 13.4% decline year to date and 127.9% over the past year. This naturally raises questions about how the current price lines up with fundamentals and risk. Recent coverage has focused on AtaiBeckley's position in the Pharmaceuticals and Biotech space and how sentiment...
NYSE:CMS
NYSE:CMSIntegrated Utilities

Michigan Grid Reliability Plan Approval Might Change The Case For Investing In CMS Energy (CMS)

Consumers Energy, a CMS Energy subsidiary, recently received regulatory approval for its 2026 Reliability Action Plan, authorizing significant upgrades to Michigan’s electric grid to improve service for nearly 2 million homes and businesses affected by severe weather. This approval reinforces regulatory backing for continued grid investment, potentially strengthening CMS Energy’s position as Michigan’s key provider of long-term electric reliability and infrastructure resilience. We’ll now...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

A Look At Wynn Resorts (WYNN) Valuation After Recent Share Price Weakness

Recent share performance and business snapshot Wynn Resorts (WYNN) shares closed at US$96.59, with the stock showing a 2.9% decline over the past day and a 3.4% decline over the past week, prompting fresh attention from investors. Over the past month the stock has recorded a 10.7% decline and over the past 3 months a 21.0% decline, alongside a value score of 2 that may lead some investors to reassess how they view the company. Wynn Resorts generates US$7.14b in revenue and US$327.33m in net...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

AMD Talks With U.S. Commerce Chief Put AI Supply Chain In Focus

AMD (NasdaqGS:AMD) CEO Lisa Su hosted U.S. Commerce Secretary Gina Raimondo for high-level talks on semiconductor leadership and domestic manufacturing. The meeting focused on AMD's role in the U.S. technology supply chain and ongoing national semiconductor initiatives. For investors watching AMD (NasdaqGS:AMD), this kind of direct engagement with the Commerce Department highlights how central chip design and manufacturing capacity have become to U.S. industrial priorities. AMD designs...
NasdaqGS:ZYME
NasdaqGS:ZYMEBiotechs

Is New ZW191 and Pan-RAS ADC Data Acceptance Shifting The Investment Case For Zymeworks (ZYME)?

In March 2026, Zymeworks Inc. reported that an oral presentation of new Phase 1 clinical data for its folate receptor alpha-targeting antibody-drug conjugate ZW191, along with six additional abstracts from its wholly owned oncology R&D portfolio, had been accepted for the American Association for Cancer Research Annual Meeting in San Diego. The breadth of clinical and preclinical data, spanning ZW191 and multiple pan-RAS inhibitor antibody-drug conjugate candidates across RAS-mutated and...
NYSE:TGLS
NYSE:TGLSBuilding

Dividend Hike And Insider Buying Could Be A Game Changer For Tecnoglass (TGLS)

Tecnoglass Inc. previously declared a quarterly dividend of US$0.15 per share for the first quarter of 2026, payable on April 30 to shareholders of record on March 31, while 10% owner Energy Holding Corp recently acquired 306,666 shares in open-market purchases. This combination of continued cash returns via dividends and fresh insider buying highlights confidence in Tecnoglass’s capital allocation and business outlook despite earlier earnings underperformance. With insider buying...
NYSE:EXPD
NYSE:EXPDLogistics

Is It Time To Reassess Expeditors International (EXPD) After Recent Share Price Weakness

If you are wondering whether Expeditors International of Washington is fairly priced or if the market is overlooking something, this article focuses squarely on what you are getting for the current share price. The stock last closed at US$141.22, with returns of 19.4% over 1 year, 32.9% over 3 years and 37.5% over 5 years. Year to date, the share price shows a 7.0% decline, including a 3.5% decline over the past week and 2.6% over the past month. Recent news coverage has largely centered on...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Is Mondelez International (MDLZ) Attractive After Mixed Share Performance And DCF Upside Estimate

If you are wondering whether Mondelez International at around US$58.27 is a bargain or just fairly priced, you are not alone. The stock has had a mixed run, with a 3.7% gain over the past week, a 5.4% decline over the last 30 days, an 8.6% return year to date, and a 11.2% loss over the past year. Recent headlines have focused on Mondelez International as a global snacks player, with investors weighing brand strength, cost pressures, and consumer demand trends. That context has been important...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

A Look At Olema Pharmaceuticals (OLMA) Valuation After Earnings And New Shelf Registration Filing

Why Olema’s latest earnings and shelf filing matter for investors Olema Pharmaceuticals (OLMA) has drawn fresh attention after reporting fourth quarter and full year 2025 results, along with a new shelf registration of up to US$71.82 million in common stock. The company posted a fourth quarter net loss of US$46.06 million and a full year 2025 net loss of US$162.45 million. It also registered 4,882,586 shares for an ESOP related offering that could affect future dilution and funding...